BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

Amgen and NSG Biolabs award first Golden Ticket in Singapore to Albatroz Therapeutics

Leading global biotechnology company Amgen and NSG BioLabs, Singapore's largest and leading provider of biotechnology (biotech) co-working labora...

March 20, 2023 | News

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Ill...

March 15, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

March 14, 2023 | News

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules

“We are thrilled to offer this cutting-edge technology to the research community,” says Jos Joore, co-CEO of MIMETAS. “We&rsquo...

March 08, 2023 | News

Debiopharm Acquires Global Rights for Novo Nordisk's USP1 Inhibitor Development.

Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments to cure can...

March 02, 2023 | News

GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, announced the expansion of its Singapor...

March 01, 2023 | News

SK bioscience’s Shingles Vaccine Secures the Highest Market Share in South Korea

‘SKYZoster®, ' the world second developed shingles vaccine secures 54% of the South Korean market share With proven immunogenicity and s...

February 28, 2023 | News

Merck Unveils Promising Four-Year Safety and Efficacy Data for Evobrutinib, Investigational BTK Inhibitor in RMS

Data from the ongoing Phase II extension showed treatment benefits of evobrutinib were maintained over four years and remained consistent with the effica...

February 27, 2023 | News

Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences

Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the f...

February 21, 2023 | News

Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease

Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...

February 21, 2023 | News

Bio-techne and Cell Signaling Technology Announce Partnership to Validate Simple Western Antibodies

Simple Western systems from ProteinSimple, a Bio-Techne brand, are the only fully automated western blotting solutions for protein detection and ch...

February 16, 2023 | News

Merck announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial

Long-term follow-up of the Phase III JAVELIN Bladder 100 study demonstrated median overall survival from start of chemotherapy of 29.7 months among patie...

February 16, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

February 16, 2023 | News

Stay Connected